Treating avian influenza infections

Details Treating avian influenza infections Treating avian influenza infections

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/13 (2006.01) A61K 31/221 (2006.01) A61K 31/351 (2006.01) A61K 31/7056 (2006.01) A61K 31/713 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2525202

Avian influenza is treated with natural human alpha interferon, neuraminidase inhibitor(s) and ribavirin. Effects of influenza virus are mitigated with a dsRNA in combination with a neuraminidase influenza virus inhibitor. These two products, dsRNA, and alpha interferon, have therapeutic utility either given preventively (prophylactically) or in treatment of active disease. These unique immunological/antiviral actions, operating through immunological "cascades" ameliorates the lethal effects of viral mutation which, by causing resistance to commonly available drugs, greatly accelerates the death rate. For example, in 1918-1920, Avian Influenza caused the death of approximately 40 million people worldwide (ref. National Geographic, Sept. 2005).

Affiliated with

Also associated with

Rating

Treating avian influenza infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating avian influenza infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating avian influenza infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1377174